← Back to Search

Reading Education Program for Dyslexia

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
No major contraindication for MRI (braces, metal implants, pacemakers, vascular stents, or metallic ear tubes)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline (within 2 weeks pre-intervention) and post-intervention (1 year follow-up)
Awards & highlights

Study Summary

This trial will use neuroimaging and reading education programs to study how the brain develops in children with dyslexia, in order to improve treatment methods.

Who is the study for?
This trial is for children with dyslexia, which means they have trouble reading accurately or fluently. They must be native English speakers without braces, metal implants, pacemakers, stents, or metallic ear tubes that would interfere with MRI scans. They should not have neurological disorders or significant psychiatric problems and cannot be claustrophobic.Check my eligibility
What is being tested?
The study tests the 'Lindamood-Bell Seeing Stars' program to see how it affects brain development related to reading skills in children with dyslexia. It uses advanced neuroimaging methods to understand individual learning differences and aims at personalizing dyslexia treatment.See study design
What are the potential side effects?
Since this intervention involves educational programs rather than medication, traditional side effects are not expected. However, participants may experience discomfort from sitting still during MRI scans or stress related to testing environments.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't have metal implants, braces, pacemakers, stents, or ear tubes that prevent MRI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline (within 2 weeks pre-intervention) and post-intervention (1 year follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline (within 2 weeks pre-intervention) and post-intervention (1 year follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
White matter plasticity

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Lindamood-Bell Seeing StarsExperimental Treatment1 Intervention
Subjects receive reading instruction focusing on the building blocks of reading
Group II: ControlActive Control1 Intervention
Subjects are followed longitudinally but do not receive intervention

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,411 Previous Clinical Trials
17,462,899 Total Patients Enrolled

Media Library

Lindamood-Bell Seeing Stars Clinical Trial Eligibility Overview. Trial Name: NCT04323488 — N/A
Dyslexia Research Study Groups: Control, Lindamood-Bell Seeing Stars
Dyslexia Clinical Trial 2023: Lindamood-Bell Seeing Stars Highlights & Side Effects. Trial Name: NCT04323488 — N/A
Lindamood-Bell Seeing Stars 2023 Treatment Timeline for Medical Study. Trial Name: NCT04323488 — N/A
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top